The impact of adoption of a new urate-lowering agent on trends in utilization and cost in practice

OBJECTIVES: Changes in treatment choice of therapy and size of treated population that can lead to under- or overestimate of payer’s budget are less likely to be reassured after reimbursement adoption of a new drug. The aim of this study was to evaluate the effects of febuxostat introduction and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yueh-Lung, Lee, Chien-Te, Tain, You-Lin, Huang, Yaw-Bin, Chuang, Hung-Yi, Wen, Yen-Hsia, Huang, Shiou-Huei, Tsai, Chun-Yu, Hsu, Chien-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709886/
https://www.ncbi.nlm.nih.gov/pubmed/31449565
http://dx.doi.org/10.1371/journal.pone.0221504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709886/
https://www.ncbi.nlm.nih.gov/pubmed/31449565
http://dx.doi.org/10.1371/journal.pone.0221504

Ejemplares similares